Back
Ensysce Biosciences Vs. Relmada Therapeutics Industry Stock Comparison
Sell
9
ENSC
Ensysce Biosciences
Last Price:
0.59
Seasonality Move:
-20.81%
Sell
24
RLMD
Relmada Therapeutics
Last Price:
3.01
Seasonality Move:
-17.02%
Sell
9
Ensysce Biosciences (ENSC)
is a Sell
Is Ensysce Biosciences a Buy, Sell or Hold?
- The current Ensysce Biosciences [ENSC] share price is $0.59. The Score for ENSC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- ENSC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
24
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy, Sell or Hold?
- The current Relmada Therapeutics [RLMD] share price is $3.04. The Score for RLMD is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENSC Stock Price Chart
What is Ensysce Biosciences's stock price today?
-
The Ensysce Biosciences share price today is $0.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENSC is experiencing slight buying pressure.
RLMD Stock Price Chart
What is Relmada Therapeutics's stock price today?
-
The Relmada Therapeutics share price today is $3.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight buying pressure.
ENSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.75 | Sell |
| Chaikin Money Flow: | 28920 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.63) | Sell |
| Bollinger Bands (100): | (0.58 - 1.18) | Sell |
RLMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 30.92 | Sell |
| Chaikin Money Flow: | 5179 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.17 - 3.77) | Sell |
| Bollinger Bands (100): | (3.45 - 5.47) | Sell |
ENSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.62 | Sell |
| 20-day SMA: | 0.59 | Sell |
| 50-day SMA: | 0.66 | Sell |
| 200-day SMA: | 1.09 | Sell |
| 8-day EMA: | 0.6 | Sell |
| 20-day EMA: | 0.61 | Sell |
| 50-day EMA: | 0.67 | Sell |
| 200-day EMA: | 7.28 | Sell |
RLMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.08 | Sell |
| 20-day SMA: | 3.42 | Sell |
| 50-day SMA: | 4.01 | Sell |
| 200-day SMA: | 3.77 | Sell |
| 8-day EMA: | 3.1 | Sell |
| 20-day EMA: | 3.38 | Sell |
| 50-day EMA: | 3.87 | Sell |
| 200-day EMA: | 4.26 | Sell |
Ensysce Biosciences Earnings Growth & ENSC Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.03 per share, an increase next quarter of $0.21 per share, an increase this year of $17.95 per share, and an increase next year of $1.37 per share.
Relmada Therapeutics Earnings Growth & RLMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.26 per share.
Ensysce Biosciences Technical Analysis
| May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Relmada Therapeutics Technical Analysis
| May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||